Gamma-Aminobutyric acid

Sep 20, 2019

GABA Therapeutics and ATAI Life Sciences Partner to Develop a Novel GABA Modulator for the Treatment of Mood Disorders

Sep 11, 2019

AgeneBio Announces Additional Funding to Advance Novel GABA-A Therapeutic Program to Address Alzheimer's and Other CNS Conditions

May 10, 2019

Pharm Origins Announces the Release of GABASOM Sublingual Sleep Formula

Mar 06, 2019

Okayama University Research: Inflammation in the Brain Enhances the Side-effects of Hypnotic Medication

Jan 03, 2018

Indivior and Addex Enter Strategic Collaboration to Accelerate Development of GABA(B) PAMs for Addiction Disorder Treatments

Nov 30, 2017

Smartphone Addiction Creates Imbalance in Brain

Oct 24, 2017

Aldeyra Therapeutics Presents Evidence for Aldehyde Sequestration as a Potential Therapeutic Approach in Succinic Semialdehyde Dehydrogenase Deficiency at the American Society of Human Genetics 2017 Annual Meeting

Oct 05, 2017

Aldeyra Therapeutics Announces Presentation of Novel Data on the Efficacy of ADX-102 in a Model of Succinic Semialdehyde Dehydrogenase Activity at the 2017 American Society of Human Genetics Annual Meeting

Aug 28, 2017

Endo Begins Shipment of Generic Sabril® (vigabatrin) for Oral Solution